# EPIVIR

NDC: 49702-203
Generic name: lamivudine
Labeler / Manufacturer: ViiV Healthcare Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20101004

FDA application: NDA020564

## Active ingredients

- LAMIVUDINE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49702-203"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49702-203
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89226149-47fa-4f7d-bb1f-1aa7034486b8